Darrin R. Uecker's most recent trade in Pulse Biosciences Inc was a trade of 15,000 Common Stock done at an average price of $16.4 . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 16.40 per share. | 12 Jun 2025 | 15,000 | 137,872 (0%) | 0% | 16.4 | 246,000 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 15.98 per share. | 12 Jun 2025 | 15,000 | 122,872 (0%) | 0% | 16.0 | 239,700 | Common Stock |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | 12 Jun 2023 | 7,365 | 0 | - | - | Warrant (right to buy) | ||
| Pulse Biosciences Inc | Darrin R. Uecker | Director, Chief Technology Officer | 12 Jun 2023 | 7,365 | 148,941 (0%) | 0% | 2.0 | 15,098 | Common Stock | |
| Pulse Biosciences Inc | Darrin R. Uecker | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2023 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Jun 2022 | 7,365 | 7,365 | - | - | Warrant (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director | 09 Jun 2022 | 7,365 | 137,376 (0%) | 0% | - | Common Stock | ||
| Pulse Biosciences Inc | Darrin R. Uecker | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 54,750 | 54,750 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 37,500 | 37,500 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, CEO and President | 25 Jan 2021 | 1,284 | 127,893 (0%) | 0% | 7.0 | 9,001 | Common Stock | |
| Pulse Biosciences Inc | Darrin R. Uecker | Director, CEO and President | 25 Jan 2021 | 1,284 | 0 | - | - | Warrant (right to buy) |